| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| prostaglandin E>1<-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| E series prostaglandin adverse reaction |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone adverse reaction |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Gemeprost adverse reaction |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil adverse reaction |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to E series prostaglandin (finding) |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to dinoprostone |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to gemeprost |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to alprostadil (finding) |
Causative agent |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoproston 10 mg vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoproston 1 mg/ml koncentrat til infusionsvæske, ampul a 0,75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml med diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 400 microgram/mL vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 3 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing gemeprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Gemeprost 1 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 500 µg/ml koncentrat til infusionsvæske, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 5 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10 µg cylinderampul med injektionsvæske, startpakning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20 µg cylinderampul med injektionsvæske, startpakning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 125 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 250 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 500 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 1000 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40 µg cylinderampul med injektionsvæske, startpakning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20 µg cylinderampul med injektionsvæske i sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10 µg cylinderampul med injektionsvæske i sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing dinoprostone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing dinoprostone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 5mcg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20,2 µg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40,0 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 10mg insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10,16 µg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil suppositorium a 125 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil suppositorium a 250 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil suppositorium a 500 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil suppositorium a 1000 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 500 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
FHIR